- Home
- SRCE vs TVTX Comparison
SRCE vs TVTX Comparison
Compare SRCE & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRCE
- TVTX
- Stock Information
- Founded
- SRCE 1863
- TVTX 2008
- Country
- SRCE United States
- TVTX United States
- Employees
- SRCE N/A
- TVTX N/A
- Industry
- SRCE Major Banks
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- SRCE Finance
- TVTX Health Care
- Exchange
- SRCE Nasdaq
- TVTX Nasdaq
- Market Cap
- SRCE 1.3B
- TVTX 1.7B
- IPO Year
- SRCE N/A
- TVTX N/A
- Fundamental
- Price
- SRCE $60.75
- TVTX $20.42
- Analyst Decision
- SRCE Buy
- TVTX Strong Buy
- Analyst Count
- SRCE 2
- TVTX 14
- Target Price
- SRCE $72.00
- TVTX $33.31
- AVG Volume (30 Days)
- SRCE 100.1K
- TVTX 1.6M
- Earning Date
- SRCE 04-24-2025
- TVTX 05-01-2025
- Dividend Yield
- SRCE 2.47%
- TVTX N/A
- EPS Growth
- SRCE 14.42
- TVTX N/A
- EPS
- SRCE 5.69
- TVTX N/A
- Revenue
- SRCE $388,840,000.00
- TVTX $273,533,000.00
- Revenue This Year
- SRCE $11.68
- TVTX $68.31
- Revenue Next Year
- SRCE $2.88
- TVTX $55.65
- P/E Ratio
- SRCE $10.81
- TVTX N/A
- Revenue Growth
- SRCE 7.96
- TVTX 75.65
- 52 Week Low
- SRCE $48.97
- TVTX $6.01
- 52 Week High
- SRCE $68.13
- TVTX $25.29
- Technical
- Relative Strength Index (RSI)
- SRCE 61.39
- TVTX 62.46
- Support Level
- SRCE $59.83
- TVTX $19.65
- Resistance Level
- SRCE $61.87
- TVTX $22.07
- Average True Range (ATR)
- SRCE 1.51
- TVTX 1.07
- MACD
- SRCE 0.53
- TVTX 0.35
- Stochastic Oscillator
- SRCE 95.09
- TVTX 78.78
About SRCE 1st Source Corporation
1st Source Corp, along with its subsidiary, offers banking services. The bank provides Commercial, Agricultural, and Real Estate Loans, which are given to privately owned business clients mainly located within the regional market areas, Consumer Services that consist of the full range of consumer banking products and services, Trust and Wealth Advisory Services, and Insurance services to individuals and business clients. Its Specialty Finance Group offers financing services for construction equipment, new and pre-owned private and cargo aircraft, and various vehicle types for fleet purposes.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.